@NorthwestBio

We are a biotech company developing personalized immune therapies (DCVax®) to treat solid tumor cancers. http://t.co/BHgOw2kDjA

 USA
nwbio.com/
Joined July 2011
  • Tweets750
  • Following2.6K
  • Followers3.1K
14Media
Join @NorthwestBio on Sunday, June 3, at 4:15 (CT) at #ASCO2018 as Dr. Marnix L. Bosch, Chief Technical Officer of NW Bio, will discuss the interim data that was published on May 29 from the Company’s Phase 3 trial of DCVax®-L for newly diagnosed #Glioblastoma brain #cancer.
11
14
4
45
Can’t attend? Watch the webcast at nwbio.com/dcvax-personalized….

Webcast: Dr. Marnix Bosch's Presentation on DCVax® from ASCO 2018 - Northwest Biotherapeutics

nwbio.com
3
12
2
34
.@NorthwestBio Announces Scientific Publication of Interim Survival Data From Phase 3 Trial of DCVax®-L for #Glioblastoma Brain #Cancer. nwbio.com/nwbio-announces-sc…

NW Bio Announces Scientific Publication of Interim Survival Data From Phase 3 Trial of DCVax®-L for...

Median survival of top 100 patients is 40.5 months, Median survival of all 331 patients is 23.1 months, Longest survivors have exceeded 7 years BETHESDA, Md., May 29, 2018 – Northwest Biotherapeutics...

nwbio.com
3
5
27
The Poster & accompanying presentation will be posted on the $NWBO website following the presentation at nwbio.com/webcasts/ #DCVax
1
2
17
$NWBO presentation at Int'l Cancer Immunotherapy Conference will be presented in the 6:45-8:45pm ET Session A today ow.ly/Sijcq
2
2
8
$NWBO CTO Dr. Marnix Bosch to present a new DCVax-Direct poster at Inaugural Int'l Cancer Immunotherapy Conference ow.ly/Sii17
2
4
18
$NWBO to Present at 4th Annual @SMIpharm Cancer Vaccines Conference in London Today at 1:30pm BST (8:30am ET) ow.ly/SbPY2 #DCVAX
4
6
10
Press Release: NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing finance.yahoo.com/news/nw-bi… $NWBO #NWBO
2
7
8
Promising new data on Phase I trial of DCVax-Direct for direct injection into all types of inop. solid tumors ow.ly/NJxN7 $NWBO
2
8
Findings to date from $NWBO's DCVax-Direct Phase I trial relating to immunological responses include the following: ow.ly/NMTzL
4
$NWBO looks forward to proceeding w/ Phase II trials applying lessons learned from this informative Phase I trial ow.ly/NJyoa
3
5
Data to date from DCVax-direct Phase I trial: 86% of Phase I patients treated w/ preferred method still alive ow.ly/NJxSW $NWBO
7
6
ICYMI: Watch Dr. Marnix L. Bosch give an overview of $NWBO's #DCVax direct Phase 1 trial here: ow.ly/NFICA #ASCO15
3
6
Press Release: $NWBO Announces Data to Date From #DCVax-Direct Phase I Trial ow.ly/NJwJN #cancer
2
4
Great Industry Expert Theater Presentation by Dr. Marnix Bosch, CTO at $NWBO today. #ASCO15
1
7
15
Happy to be at #ASCO15 - stop by and see us!
4
11
Check out Dr. Marnix Bosch's presentation @NYASEvents' conference on emerging approaches to #immunotherapy: ow.ly/NfGkS $NWBO
2
5
.@NYASEvents' conference on emerging approaches to immunotherapy, $NWBO's Dr. Marnix Bosch will discuss #DCVax-Direct ow.ly/NffdK

NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunothe...

/PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer,...

prnewswire.com
1
3
$NWBO to present at @NYASEvents' conference on emerging approaches to #immunotherapy today. Learn more: ow.ly/Nfaqh

NW Bio To Present At New York Academy Of Sciences' Conference On Emerging Approaches To Immunothe...

/PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for cancer,...

prnewswire.com
3
4
Tomorrow, Linda Powers, $NWBO CEO, will present a live overview of our #DCVax cancer vaccine platform. Learn more: ow.ly/MAN34
1
3
Load more